Academic And Community Cancer Research United

This early-phase trial tests whether combining regorafenib (a targeted therapy) with durvalumab (an immunotherapy) can shrink tumors in 4 adults with high-risk liver cancer before surgery. The goal is to see if the treatment reduces tumor size enough to improve surgical outcomes.…

This study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 and older (or younger people who cannot take standard chemotherapy) with untreated Hodgkin lymphoma. The goal is to see how well these drugs control the cancer by helping the immune …

This study tests whether a natural supplement called PEA can reduce nerve pain, numbness, and tingling caused by chemotherapy in 88 cancer patients. Participants must have had these symptoms for at least 3 months after finishing chemo. The trial compares PEA to a placebo over 8 w…